Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics
Status:
Not yet recruiting
Trial end date:
2022-06-02
Target enrollment:
Participant gender:
Summary
the investigators hypothesized that Nalbuphine may be alternative pharmacological agent for
prevention of emergence agitation in pediatrics who will be scheduled for elective lower
abdominal surgical procedures (inguinal hernia repair and hypospadias) during sevoflurane
anesthesia